Impact of Smoking History on the Efficacy of Gefitinib in Patients with Non-Small Cell Lung Cancer Harboring Activating Epidermal Growth Factor Receptor Mutations

Publisher： Karger

E-ISSN： 1423-0232|89|5|275-280

ISSN： 0030-2414

Source： Oncology, Vol.89, Iss.5, 2015-0, pp. : 275-280

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparison of the Efficacy of Gefitinib in Patients with Non-Small Cell Lung Cancer according to the Type of Epidermal Growth Factor Receptor Mutation

By  

Oncology, Vol. 87, Iss. 4, 2014-07 ,pp. : 215-223

Karger

Access to resources Recommend Favorite

Discrepancy between the Clinical Image and Pathological Findings of Non-Small Cell Lung Cancer Harboring an Epidermal Growth Factor Receptor Gene Mutation That Was Surgically Resected after Gefitinib Treatment

By  

Case Reports in Oncology, Vol. 7, Iss. 1, 2014-02 ,pp. : 126-131

Karger

Access to resources Recommend Favorite

Epidermal Growth Factor Receptor Inhibition and Non-Small Cell Lung cancer

By von Eyben Finn  

Critical Reviews in Clinical Laboratory Sciences, Vol. 43, Iss. 4, 2006-08 ,pp. : 291-323

Informa Healthcare

Access to resources Recommend Favorite

Targeting the Epidermal Growth Factor Receptor in Non-Small Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 33, Iss. 12, 2010-11 ,pp. : 704-709

Karger

Access to resources Recommend Favorite

Rebiopsy of non–small cell lung cancer patients with acquired resistance to epidermal growth factor receptor‐tyrosine kinase inhibitor

By  

CANCER, Vol. 119, Iss. 24, 2013-12 ,pp. : 4325-4332

John Wiley & Sons Inc

Access to resources Recommend Favorite